118 related articles for article (PubMed ID: 2509075)
1. Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum--a possible indicator of non-A, non-B hepatitis.
Emmanuel JC; Bassett MT; Smith HJ; Paterson LE
Cent Afr J Med; 1989 Aug; 35(8):469-70. PubMed ID: 2509075
[No Abstract] [Full Text] [Related]
2. Screening of donor blood for alanine aminotransferase.
Fiedler H
JAMA; 1985 Dec; 254(24):3422. PubMed ID: 3934400
[No Abstract] [Full Text] [Related]
3. Posttransfusion hepatitis: clinical features, risk and donor testing.
Alter HJ
Prog Clin Biol Res; 1985; 182():47-61. PubMed ID: 3929262
[No Abstract] [Full Text] [Related]
4. A review of donor alanine aminotransferase testing. Implications for the blood donor and practitioner.
Saxena S; Korula J; Shulman IA
Arch Pathol Lab Med; 1989 Jul; 113(7):767-71. PubMed ID: 2500923
[TBL] [Abstract][Full Text] [Related]
5. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
Lenes BA; Tomasulo P; Alter HJ; Holland PV
N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702
[No Abstract] [Full Text] [Related]
6. Alanine aminotransferase levels in Hispanics.
Carter-Pokras OD; Najjar MF; Billhymer BF; Shulman IA
Ethn Dis; 1993; 3(2):176-80. PubMed ID: 8324495
[TBL] [Abstract][Full Text] [Related]
7. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
[No Abstract] [Full Text] [Related]
8. [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
Grunenberg R; Banik N; Krüger J
Infusionsther Transfusionsmed; 1995 Jun; 22(3):145-51. PubMed ID: 7640509
[TBL] [Abstract][Full Text] [Related]
9. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis.
Steinbrecher UP; Kovacs TO; Gelly A; Tourigny M
Clin Invest Med; 1983; 6(4):327-30. PubMed ID: 6671363
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of blood donors with elevated serum alanine aminotransferase levels.
Friedman LS; Dienstag JL; Watkins E; Hinkle CA; Spiers JA; Rieder SV; Huggins CE
Ann Intern Med; 1987 Aug; 107(2):137-44. PubMed ID: 3111321
[TBL] [Abstract][Full Text] [Related]
11. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857
[No Abstract] [Full Text] [Related]
12. Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipients.
Mishler JM; Barbosa L; Mihalko LJ; McCarter H
JAMA; 1981 Nov; 246(20):2340-4. PubMed ID: 6795368
[TBL] [Abstract][Full Text] [Related]
13. [Behavior of gamma-glutamyltranspeptidase in acute viral hepatitis].
Cauda R; Miggiano G; Tamburrini E; Mordente A; Laghi V
Quad Sclavo Diagn; 1983 Jun; 19(2):192-203. PubMed ID: 6145180
[TBL] [Abstract][Full Text] [Related]
14. [Chronic active non-A, non-B hepatitis].
Moreira Vicente VF; Barcena Marugán R; Hernández Ranz F; Milicua Salamero JM; Martín Scapa MA; Ruiz del Arbol L; Bueno Vallejo R; Gil Grande LA; Suárez García E; García Plaza A
Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):270-86. PubMed ID: 6419304
[No Abstract] [Full Text] [Related]
15. [Diagnostic criteria in post-transfusion non-A, non-B hepatitis].
Katayama T
Nihon Rinsho; 1988 Dec; 46(12):2635-8. PubMed ID: 3149335
[No Abstract] [Full Text] [Related]
16. The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis.
Gitlin N
Am J Gastroenterol; 1982 Jan; 77(1):2-4. PubMed ID: 6801971
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of high ALAT and serologic markers of hepatitis B virus in blood donors incriminated in non-A, non-B posttransfusion hepatitis].
Pascasio Acevedo JM; Bárcena Marugán R; Zamora C; Suárez García E; Moreira Vicente VF; Ruiz del Arbol Olmo L; González Martín JA; Gil Grande LA; Larraona Moreno JL; Simón Marco MA
Rev Clin Esp; 1987 Feb; 180(3):142-6. PubMed ID: 3107091
[No Abstract] [Full Text] [Related]
18. Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers.
Cleavinger PJ; Persing DH; Li H; Moore SB; Charlton MR; Sievers C; Therneau TM; Zein NN
Am J Gastroenterol; 2000 Mar; 95(3):772-6. PubMed ID: 10710073
[TBL] [Abstract][Full Text] [Related]
19. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
[TBL] [Abstract][Full Text] [Related]
20. [Non A non B hepatitis--what is it then?].
Pavlotzky M; Eshchar J
Harefuah; 1982 Mar; 102(5):207-9. PubMed ID: 6811388
[No Abstract] [Full Text] [Related]
[Next] [New Search]